Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 10, 2017
Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measuresJin-Shei Lai, Siera Goodnight, Nancy R Downing, et al.
Diagnostic Microbiology and Infectious Disease|May 2, 2026
Analytical performance of the AMDI™ Fast PCR Mini Respiratory PanelLouis Geller, Alyssa Fiore, Liza Perez, et al.
Cell Death & Disease|September 26, 2020
pS421 huntingtin modulates mitochondrial phenotypes and confers neuroprotection in an HD hiPSC modelXiaohong Xu, Bryan Ng, Bernice Sim, et al.
JMIR Mental Health|March 6, 2023
Digital Practices by Citizens During the COVID-19 Pandemic: Findings From an International Multisite StudyHannah Ramsden Marston, Pei-Chun Ko, Vishnunarayan Girishan Prabhu, et al.
Cell Host & Microbe|May 31, 2024
Mechanism of phage sensing and restriction by toxin-antitoxin-chaperone systemsToomas Mets, Tatsuaki Kurata, Karin Ernits, et al.
EMBO Molecular Medicine|June 17, 2015
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacyBryan W Miller, Jennifer P Morton, Mark Pinese, et al.
The Journal of Molecular Diagnostics : JMD|May 27, 2026
Multicenter Clinical Comparison of the 10 Minute AMDI Fast PCR Mini Respiratory Panel and the Cepheid Xpert Xpress CoV-2/Flu/RSV plusAravind Srinivasan, Regina Martin, Gregory Allen, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
Pageof 4